Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

• Status: Withdrawn
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lund University Hospital
• Collaborator: Bayer
• Treatments: Iloprost

Criteria

Inclusion Criteria:

• Elevated arterial pulmonary pressure

• GA > 24 GW

• 24-48 hours of age

• Ventilator treatment

Exclusion Criteria:

• Congenital anomalies

• Severe hypotension